Needlefree and glass syringe


Intravenous news: report “Clinicians should avoid using needleless glass syringes prefilled with 2 cardiac drugs because of continued malfunctions that can delay administration during emergencies and result in serious harm to patients, the US Food and Drug Administration (FDA) announced May 6.

The FDA’s new safety communication urges healthcare professionals working in emergency and critical care settings to instead stock crash carts, ambulances, and emergency departments with adenosine and amiodarone supplied in vials or prefilled plastic syringes.

Healthcare professionals should also “read the label of the pre-filled plastic syringes to ensure they are compatible with the access systems,” added the FDA.”

Click here for the full story.

Main page


Comments are closed.